ライフサイエンスコーパス: corticotropin

1 peptides melanocyte-stimulating hormone and corticotropin.

2 FSH)], with adrenocorticomelanotropic cells [corticotropin (ACTH) and alpha-melanotropin (alpha-MSH)]

3 in level and lack of stress- and cue-induced corticotropin and cortisol responses, higher anxiety, an

4 The production of corticotropin and cortisol was assessed in 11 specimens

5 ects of cortisol metabolism: daily levels of corticotropin and cortisol; plasma cortisol clearance, m

6 retion of cortisol suppresses the release of corticotropin by pituitary corticotrophs, which results

7 cronodular adrenal hyperplasia appears to be corticotropin-dependent.

8 ticotropin precursor proopiomelanocortin and corticotropin expression were assessed by means of a pol

9 rease <9 mug/dL after 250 mug of intravenous corticotropin from basal values <35 mug/dL.

10 lls: inositol polyphosphate-5-phosphatase A, corticotropin hormone precursor, ribosome biogenesis reg

11 A semiquantitative score for corticotropin immunostaining in the samples correlated w

12 We examined the abnormal production of corticotropin in these hyperplastic adrenal glands.

13 Corticotropin-independent Cushing's syndrome is caused b

14 Some cases of corticotropin-independent macronodular adrenal hyperplas

15 Transcriptome-based classification of corticotropin-independent macronodular adrenal hyperplas

16 Thus, the disease has been termed corticotropin-independent macronodular adrenal hyperplas

17 Corticotropin-independent macronodular adrenal hyperplas

18 and tumor DNA obtained from 33 patients with corticotropin-independent macronodular adrenal hyperplas

19 A axis dysregulation, marked by higher basal corticotropin level and lack of stress- and cue-induced

20 Serum and salivary cortisol and plasma corticotropin levels decreased, and clinical signs and s

21 However, low corticotropin levels have also been reported in critical

22 Adrenal corticotropin levels were higher in adrenal venous blood

23 er in the patients than in controls, whereas corticotropin levels were lower (P<0.001 for both compar

24 Corticotropin levels were measured in adrenal and periph

25 y corticotrophs, which results in low plasma corticotropin levels.

26 The corticotropin precursor proopiomelanocortin and corticot

27 d greater neutral, relaxed-state cortisol to corticotropin ratio (adrenal sensitivity) were each pred

28 Corticotropin-receptor antagonists significantly inhibit

29 gh an interaction between the stress hormone corticotropin releasing factor (CRF) and glutamate relea

30 The stress neuropeptide corticotropin releasing factor (CRF) and its receptors (

31 Corticotropin releasing factor (CRF) coordinates the bra

32 The stress neuropeptide corticotropin releasing factor (CRF) is anxiogenic and i

33 Here we demonstrate that, in the vBNST, corticotropin releasing factor (CRF) is expressed in neu

34 Corticotropin releasing factor (CRF) is the primary medi

35 port that the stress-associated neuropeptide corticotropin releasing factor (CRF) produces a profound

36 icotine withdrawal was mediated by increased corticotropin releasing factor (CRF) receptor-1 expressi

37 Corticotropin releasing factor (CRF) regulates physiolog

38 Corticotropin releasing factor (CRF) signaling and CRF n

39 The corticotropin releasing factor (CRF) system in the centr

40 The corticotropin releasing factor (CRF) system in the centr

41 Corticotropin releasing factor (CRF) within the ventral

42 ontains a large number of neurons expressing corticotropin releasing factor (CRF), a neuropeptide tha

43 until the corticotropes are stimulated with corticotropin releasing factor (CRF), whereupon SSTR2 ex

44 ine seeking by the stress-sensitive peptide, corticotropin releasing factor (CRF).

45 presence of the prototypical stress hormone, corticotropin releasing factor (CRF).

46 of action for the anxiogenic neuromodulator, corticotropin releasing factor (CRF).

47 he transmembrane domains of the glucagon and corticotropin releasing factor 1 (CRF1) receptors to dev

48 Corticotropin releasing factor binding protein (CRF-BP)

49 oupled receptors, which bind peptides of the corticotropin releasing factor family and are key mediat

50 technique to a member of a class B GPCR, the corticotropin releasing factor receptor 1 (CRF1R).

51 analysis showed significant upregulation of corticotropin releasing factor receptor 2 (CrfR2) in the

52 The current study examines the role of corticotropin releasing factor receptor subtypes 1 and 2

53 nvestigated here the interaction between the corticotropin releasing factor receptor type 1 (CRF1R) a

54 Corticotropin releasing factor type 1 (CRF1) is a key co

55 fering the neural stress response induced by corticotropin releasing factor, and promoting stress res

56 in stress and appetite regulation, including corticotropin releasing factor, pro-opiomelanocortin B,

57 88-induced c-Fos activation were observed in corticotropin releasing factor-containing neurons of the

58 eus of the hypothalamus and primarily in non-corticotropin releasing factor-containing neurons of the

59 rom the basolateral amygdala (BLA) away from corticotropin releasing factor-expressing (CRF(+)) centr

60 excitability induced by the stress hormone, corticotropin releasing factor.

61 ORs that colocalize with the stress hormone, corticotropin releasing factor.

62 on, and its glutamatergic neurons expressing corticotropin releasing hormone (Bar(Crh/Vglut2)) are im

63 eloped for the detection of the neuropeptide Corticotropin Releasing Hormone (CRH) based on the immob

64 ional interaction between macroautophagy and Corticotropin Releasing Hormone (Crh) in the gut.

65 Corticotropin releasing hormone (CRH) is disrupted in in

66 al requires Nmu receptor 2 and signaling via corticotropin releasing hormone (Crh) receptor 1.

67 Glucocorticoids and corticotropin releasing hormone (CRH) underlie the physi

68 ethylation of the cortisol-regulating genes, corticotropin releasing hormone (CRH; P=0.05) and glucoc

69 icosterone receptors, their regulator Fkbp5, corticotropin releasing hormone and its receptor, oxytoc

70 from the nucleus tractus solitarii (NTS) to corticotropin releasing hormone neurons in the paraventr

71 erone levels), and alleviated by antalarmin (corticotropin releasing hormone receptor 1 antagonist).

72 cluding the membrane progestin receptor, the corticotropin releasing hormone receptor, and the 5HT1a

73 Using a corticotropin releasing hormone-cre driver X tdTomato re

74 rons express dynorphin, somatostatin, and/or corticotropin releasing hormone.

75 We report that corticotropin-releasing factor (CRF) acts in the ventral

76 Although it has long been known that corticotropin-releasing factor (CRF) and CRF receptors a

77 mRNA was found to partially colocalize with corticotropin-releasing factor (CRF) and growth hormone-

78 Corticotropin-releasing factor (CRF) and nociceptin/orph

79 Release of the neuropeptides corticotropin-releasing factor (CRF) and orexin-A in the

80 Corticotropin-releasing factor (CRF) and the three relat

81 Here we report the identification of corticotropin-releasing factor (CRF) as a critical compo

82 To investigate corticotropin-releasing factor (CRF) contributions to fe

83 neurons that release the stress neuropeptide corticotropin-releasing factor (CRF) drive anxiety-like

84 regulation of the central extrahypothalamic corticotropin-releasing factor (CRF) expression is assoc

85 The corticotropin-releasing factor (CRF) family of peptides

86 Urocortin 2 (Ucn2), a peptide of the corticotropin-releasing factor (CRF) family, binds with

87 hypersecretion of the stress neuromediator, corticotropin-releasing factor (CRF) has been implicated

88 rofiling of relevant PI cells identified the corticotropin-releasing factor (CRF) homolog, DH44, as a

89 ike ShA cocaine self-administration, reduced corticotropin-releasing factor (CRF) immunodensity in th

90 ed body of work indicates a crucial role for corticotropin-releasing factor (CRF) in neurobiological

91 termined the role of the stress neurohormone corticotropin-releasing factor (CRF) in stress-induced b

92 ed on previous work hypothesizing a role for corticotropin-releasing factor (CRF) in the IC during cr

93 We recently described the existence of corticotropin-releasing factor (CRF) in the mouse cochle

94 ine was compared following overexpression of corticotropin-releasing factor (CRF) in the NAc of femal

95 literature suggests that catecholamines and corticotropin-releasing factor (CRF) interact in a seria

96 Corticotropin-releasing factor (CRF) is an important lin

97 Corticotropin-releasing factor (CRF) is critical for the

98 Corticotropin-releasing factor (CRF) is expressed in the

99 Corticotropin-releasing factor (CRF) mediates anxiogenic

100 from chronic alcohol exposure contains ~80% corticotropin-releasing factor (CRF) neurons and that th

101 Although it has long-been known that corticotropin-releasing factor (CRF) neurons are promine

102 and anxiety and activates a subpopulation of corticotropin-releasing factor (CRF) neurons in the bed

103 cohol intake specifically recruited GABA and corticotropin-releasing factor (CRF) neurons in the mPFC

104 the relationship between corticosterone and corticotropin-releasing factor (CRF) on both beta-amyloi

105 ed the effect of an intravenous injection of corticotropin-releasing factor (CRF) on fructose malabso

106 and the influence of the stress neuropeptide corticotropin-releasing factor (CRF) on these responses.

107 nced fear memory but did not increase either corticotropin-releasing factor (CRF) or corticosterone.

108 Corticotropin-releasing factor (CRF) orchestrates the st

109 The corticotropin-releasing factor (CRF) plays a key role in

110 Considerable evidence suggests that corticotropin-releasing factor (CRF) plays an important

111 The corticotropin-releasing factor (CRF) receptor 1 (CRFR1)

112 duction and Abeta elevation are dependent on corticotropin-releasing factor (CRF) receptor 1 signalin

113 Corticotropin-releasing factor (CRF) receptors are found

114 Because corticotropin-releasing factor (CRF) receptors are impli

115 We recently demonstrated that activation of corticotropin-releasing factor (CRF) receptors in the ca

116 Corticotropin-releasing factor (CRF) receptors-which bin

117 The stress-related neuropeptide, corticotropin-releasing factor (CRF) regulates the dorsa

118 induced relapse through alterations in brain corticotropin-releasing factor (CRF) regulation of neuro

119 Corticotropin-releasing factor (CRF) signaling at the CR

120 Alterations in corticotropin-releasing factor (CRF) signaling pathways

121 eviously demonstrated that activation of the corticotropin-releasing factor (CRF) system potentiates

122 The corticotropin-releasing factor (CRF) system, which is in

123 f neonatal amygdala (Neo-A) lesions on brain corticotropin-releasing factor (CRF) systems and hypotha

124 Corticotropin-releasing factor (CRF) that is released fr

125 The corticotropin-releasing factor (CRF) type 1 receptor (CR

126 Systemic blockade of corticotropin-releasing factor (CRF) type 1 receptors (C

127 clase-activating peptide, PAC1 receptor, and corticotropin-releasing factor (CRF), (CRF1) receptor.

128 Here we report that corticotropin-releasing factor (CRF), a neuropeptide rel

129 nsistent with this, the CEA highly expresses corticotropin-releasing factor (CRF), an important modul

130 (Dh44), a neuropeptide related to vertebrate corticotropin-releasing factor (CRF), and its receptor,

131 to the BNSTDL, is thought to communicate via corticotropin-releasing factor (CRF), but studies have y

132 The neuropeptide, corticotropin-releasing factor (CRF), coordinates the ph

133 ological studies indicate the involvement of corticotropin-releasing factor (CRF), noradrenaline, dop

134 es in receptors for the stress neuropeptide, corticotropin-releasing factor (CRF), that render the lo

135 Corticotropin-releasing factor (CRF), the major stress p

136 The focus is on the receptor for corticotropin-releasing factor (CRF), the orchestrator o

137 Corticotropin-releasing factor (CRF), the stress-related

138 ways expressing the stress-sensitive peptide corticotropin-releasing factor (CRF), which has been ide

139 ral amygdala noradrenergic substrates [via a corticotropin-releasing factor (CRF)-dependent mechanism

140 allenge has been shown previously to cause a corticotropin-releasing factor (CRF)-mediated increase i

141 Corticotropin-releasing factor (CRF)-mediated mechanisms

142 de transmitter in the brain that counteracts corticotropin-releasing factor (CRF)-mediated stress and

143 und that GluN2D is functionally expressed on corticotropin-releasing factor (CRF)-positive BNST cells

144 d reward, including neuropeptide Y (NPY) and corticotropin-releasing factor (CRF).

145 vation of glucocorticoid receptors (GRs) and corticotropin-releasing factor (CRF).

146 ation of VTA dopaminergic neurons expressing corticotropin-releasing factor (CRF).

147 ) system by the stress-related neuropeptide, corticotropin-releasing factor (CRF).

148 nity monoclonal antibody, CTRND05, targeting corticotropin-releasing factor (CRF).

149 amygdala (CeA) that produce the neuropeptide corticotropin-releasing factor (CRF).

150 This study tested the hypothesis that the corticotropin-releasing factor (CRF1) antagonist GSK5616

151 ist (eticlopride), D2R agonist (quinpirole), corticotropin-releasing factor 1 (CRF1) antagonist (anta

152 t of brain stress neurotransmitters, such as corticotropin-releasing factor and dynorphin, in the neu

153 alcohol drinking by increased expression of corticotropin-releasing factor and its feedback regulati

154 that promote stress and resilience, such as corticotropin-releasing factor and nociceptin, has been

155 nsatory mechanism in the brain to counteract corticotropin-releasing factor and/or stress.

156 cuses on the HPA axis-based interventions of corticotropin-releasing factor antagonists and the gluco

157 Corticotropin-releasing factor binds with high affinity

158 The neuropeptides vasopressin and corticotropin-releasing factor facilitate, while seroton

159 ephalin, thyrothropin-releasing hormone, and corticotropin-releasing factor immunoreactive cells in t

160 Corticotropin-releasing factor infusions into LA impair

161 Corticotropin-releasing factor infusions into the centra

162 s in the anterior hypothalamus that may gate corticotropin-releasing factor output from the amygdala

163 ss, the physiological consequence of central corticotropin-releasing factor receptor (CRF-R) activati

164 viously reported differential involvement of corticotropin-releasing factor receptor (CRFR) 1 and 2 i

165 We aimed to characterize the effects of the corticotropin-releasing factor receptor 1 (CRF-R1) antag

166 noradrenergic (NE) receptors (alpha1) via a corticotropin-releasing factor receptor 1 (CRF-R1)-depen

167 rial evaluating the efficacy of GSK561679, a corticotropin-releasing factor receptor 1 (CRF1 receptor

168 Blockade of corticotropin-releasing factor receptor 1 (CRF1) suppres

169 Similarly to what has been observed for the corticotropin-releasing factor receptor 1 (CRFR1), SAP97

170 me proliferator-activated receptor gamma and corticotropin-releasing factor receptor 1 were notable e

171 mutants with constitutive activation of the corticotropin-releasing factor receptor family homologue

172 anaphylaxis and psychological stress through corticotropin-releasing factor receptor subtype 1 (CRF(1

173 In this study we investigated the role of corticotropin-releasing factor receptor subtype 2 (CRF(2

174 d, we took the CRF(2(a))R and the homologous corticotropin-releasing factor receptor type 1 (CRF(1)R)

175 esent study investigated whether blockade of corticotropin-releasing factor receptor type 1 (CRF-R1)

176 n reflect reductions in anandamide driven by corticotropin-releasing factor receptor type 1 (CRF1) po

177 we investigated interactions of the class B corticotropin-releasing factor receptor type 1 (CRF1R) w

178 Corticotropin-releasing factor receptor type 1 (CRFR1) i

179 ular membrane compartments, we show that the corticotropin-releasing factor receptor type 1 has a spe

180 ure of the transmembrane domain of the human corticotropin-releasing factor receptor type 1 in comple

181 The corticotropin-releasing factor receptor type 1 is a clas

182 here this equilibrium is established for the corticotropin-releasing factor receptor type 1.

183 vation of the central stress response, while corticotropin-releasing factor receptor type 2 (CRFR2) h

184 Corticotropin-releasing factor receptor type 2 (CRFR2) h

185 eviously, we observed abnormal expression of corticotropin-releasing factor receptor type 2 (CRFR2) t

186 The corticotropin-releasing factor receptor type 2a (CRF(2(a

187 Corticotropin-releasing factor receptor-1 (CRF(1)) media

188 n in the BNST is unaffected by alpha1-AR and corticotropin-releasing factor receptor-1 (CRFR(1)) anta

189 Effects on attention were attenuated by the corticotropin-releasing factor receptor-1 antagonist ant

190 Corticotropin-Releasing Factor Receptors (CRFRs) are cla

191 Corticotropin-releasing factor receptors (CRFRs), class

192 alysis studies it has been shown to increase corticotropin-releasing factor release in extrahypothala

193 Alterations in central corticotropin-releasing factor signaling pathways have b

194 ry-adrenal axis), (4) the (gastrointestinal) corticotropin-releasing factor system, and (5) the intes

195 is function was probed using a dexamethasone/corticotropin-releasing factor test.

196 Activation of corticotropin-releasing factor type 1 (CRF1) receptors i

197 icated that repeated social stress decreased corticotropin-releasing factor type 1 receptor and incre

198 We found that corticotropin-releasing factor type 1 receptor within th

199 disrupts this LTCC-based mechanism; instead, corticotropin-releasing factor type 1 receptors (CRF1s)

200 disrupts this LTCC-based mechanism; instead, corticotropin-releasing factor type 1 receptors (CRF1s)

201 The corticotropin-releasing factor type 2 receptor (CRFR2) i

202 demonstrated that the mechanism involved the corticotropin-releasing factor type 2 receptor, cAMP ele

203 cial behavior (especially neuropeptide Y and corticotropin-releasing factor) are modulated by alcohol

204 Corticotropin-releasing factor, a stress-related neurope

205 including hypocretin/orexin, norepinephrine, corticotropin-releasing factor, and cytokines.

206 -system recruitment of brain stress systems (corticotropin-releasing factor, dynorphin, norepinephrin

207 tuitary-adrenal axis, including signaling by corticotropin-releasing factor, in the pathophysiology o

208 w stress interacts with the neuromodulators, corticotropin-releasing factor, norepinephrine, dopamine

209 were identified (i.e., serotonin, dynorphin, corticotropin-releasing factor, oxytocin).

210 ess effect by counteracting the functions of corticotropin-releasing factor, the primary stress-media

211 peptides (ghrelin, nesfatin-1, somatostatin, corticotropin-releasing factor, thyrotropin-releasing ho

212 rmittent access to palatable food results in corticotropin-releasing factor-1 (CRF1) receptor antagon

213 e diuretic hormone 44 (DH44), an ortholog of corticotropin-releasing factor.

214 They further suggest that an activated corticotropin-releasing factor/hypothalamic-pituitary-ad

215 luding those that encode the stress hormones corticotropin-releasing hormone (CRH) and adrenocorticot

216 The corticotropin-releasing hormone (CRH) and its type 1 rec

217 n-33 (IL-33), and stress molecules including corticotropin-releasing hormone (CRH) and neurotensin (N

218 larval zebrafish with transgenically labeled corticotropin-releasing hormone (CRH) cells, which repre

219 employed viral-genetic approaches to reduce corticotropin-releasing hormone (Crh) expression in the

220 axis initiates the production and release of corticotropin-releasing hormone (CRH) from the paraventr

221 activity for the suppression of hypothalamic corticotropin-releasing hormone (CRH) gene expression an

222 nstrate that a cluster of neurons expressing corticotropin-releasing hormone (Crh) in the pontine mic

223 Corticotropin-releasing hormone (CRH) is a central integ

224 Corticotropin-releasing hormone (CRH) is a major regulat

225 Corticotropin-releasing hormone (CRH) is an essential, e

226 Corticotropin-releasing hormone (CRH) is secreted under

227 Here we demonstrate that corticotropin-releasing hormone (CRH) neurons are modula

228 tin, thyrotropin-releasing hormone (TRH) and corticotropin-releasing hormone (CRH) neurons expressed

229 synaptic metaplasticity in stress-responsive corticotropin-releasing hormone (CRH) neurons in female

230 affects excitatory and inhibitory inputs to corticotropin-releasing hormone (CRH) neurons in the hyp

231 naptic plasticity at glutamate synapses onto corticotropin-releasing hormone (CRH) neurons in the par

232 tical areas transmit signals to hypothalamic corticotropin-releasing hormone (CRH) neurons, which con

233 augments excitatory synaptic strength in PVN corticotropin-releasing hormone (CRH) neurons, with GLP-

234 el synergistic actions of corticosterone and corticotropin-releasing hormone (CRH) on synaptic physio

235 ing hormone, oxytocin, arginine vasopressin, corticotropin-releasing hormone (CRH) or thyrotropin-rel

236 ress, adrenal corticosterone and hippocampal corticotropin-releasing hormone (CRH) permeate memory-fo

237 g-standing paradigm posits that hypothalamic corticotropin-releasing hormone (CRH) regulates neuroend

238 Corticotropin-releasing hormone (CRH) released from the

239 The corticotropin-releasing hormone (CRH) system coordinates

240 In addition, increased activation of the corticotropin-releasing hormone (CRH) system within the

241 working memory (WM) deficits; changes to the corticotropin-releasing hormone (CRH) system; and struct

242 rtisol concentrations and gene expression of corticotropin-releasing hormone (CRH) were not affected

243 e production and release of the neuropeptide corticotropin-releasing hormone (CRH) within the hippoca

244 Activation of amygdalar corticotropin-releasing hormone (CRH)+ neurons abolished

245 Extensive preclinical data implicate corticotropin-releasing hormone (CRH), acting through it

246 Although corticotropin-releasing hormone (CRH), produced by parvo

247 nals were collected and processed to measure corticotropin-releasing hormone (CRH), urocortin (Ucn),

248 activities by stimulating the expression of corticotropin-releasing hormone (CRH), urocortin, proopi

249 multilabeled for vasotocin, mesotocin (MT), corticotropin-releasing hormone (CRH), vasoactive intest

250 ormone 44 (Dh44), a homolog of the mammalian corticotropin-releasing hormone (CRH), were specifically

251 ticoids and the stress-released neuropeptide corticotropin-releasing hormone (CRH), which influence t

252 evious studies have described the effects of corticotropin-releasing hormone (CRH), which is released

253 he adult brain, we have virally traced local corticotropin-releasing hormone (CRH)-expressing inhibit

254 nced vertebrate genomes for genes resembling corticotropin-releasing hormone (CRH).

255 ed subset of OXT neurons that co-express the corticotropin-releasing hormone (CRH).

256 al stress physiology, specifically placental corticotropin-releasing hormone (pCRH).

257 found that the rs28365143 variant within the corticotropin-releasing hormone binding protein (CRHBP)

258 The corticotropin-releasing hormone family mediates function

259 Neurons expressing the corticotropin-releasing hormone gene (Crh) in central am

260 MNL-CMR-associated PTD showed higher CRP and corticotropin-releasing hormone levels.

261 loss-of-function mice, either with global or corticotropin-releasing hormone neuron-specific deletion

262 ds of aberrant membrane receptors but not by corticotropin-releasing hormone or dexamethasone.

263 The type 1 corticotropin-releasing hormone receptor (CRH-R1) influe

264 gated expression of stress-response receptor corticotropin-releasing hormone receptor (CRHR) in bladd

265 e other ligand-binding site defined--for the corticotropin-releasing hormone receptor 1 (CRF1R)--whic

266 Corticotropin-releasing hormone receptor 1 (CRHR1) activ

267 Variations in the corticotropin-releasing hormone receptor 1 (CRHR1) gene

268 In addition, GR and corticotropin-releasing hormone receptor 1 (CRHR1) genot

269 51 [FKBP5], glucocorticoid receptor [NR3C1], corticotropin-releasing hormone receptor 1 [CRHR1]) in i

270 elch-like protein 2)), chromosome 17 (CRHR1 (corticotropin-releasing hormone receptor 1) and MAPT (mi

271 7, rs77804065 (p = 1.5 x 10(-12)), at CRHR1 (corticotropin-releasing hormone receptor 1); the protein

272 opeptide urocortin 2 (UCN2) and its receptor corticotropin-releasing hormone receptor 2 (CRHR2) are h

273 Activation of corticotropin-releasing hormone receptor 2 (CRHR2) in th

274 5-2 muM) for 6 hours significantly increases corticotropin-releasing hormone receptor-1 (CRHR-1) mRNA

275 found a significant three-way interaction on corticotropin-releasing hormone receptor-1 (Crhr1) gene

276 bellar Purkinje cells, and co-localized with corticotropin-releasing hormone receptors in the latter.

277 stress-coping responses by binding to type 2 corticotropin-releasing hormone receptors.

278 in both the initial and replication samples: corticotropin-releasing hormone signaling, cardiac beta-

279 l enrichment analyses revealed enrichment of corticotropin-releasing hormone signaling, GNRH signalin

280 Furthermore, endogenous corticotropin-releasing hormone(+) (CRH(+)) LC inputs fr

281 way in rat paraventricular hypothalamic CRH (corticotropin-releasing hormone) neuroendocrine neurons

282 CRH (corticotropin-releasing hormone), a peptide released fro

283 ernal blood (i.e., C-reactive protein (CRP), corticotropin-releasing hormone, and cytokines) were com

284 at several peptide markers (cholecystokinin, corticotropin-releasing hormone, and tachykinin 1) label

285 not GABAergic, and do not express oxytocin, corticotropin-releasing hormone, vasopressin, or prodyno

286 mic activation of the pituitary changes from corticotropin-releasing hormone-dominant to arginine vas

287 In addition, we discovered that corticotropin-releasing hormone-expressing cells contain

288 f inhibition by dynorphin, somatostatin, and corticotropin-releasing hormone-expressing neurons in th

289 al raphe-originating serotonergic control of corticotropin-releasing hormone-mediated excitation of t

290 refrontal cortex restrains the amygdala, the corticotropin-releasing hormone/hypothalamic-pituitary-a

291 We demonstrate that corticotropin-releasing-hormone-binding protein (CRHBP),

292 ts potential use as a targeted treatment for corticotropin-secreting pituitary adenomas.

293 We evaluated adrenal function using short corticotropin stimulation test in 157 episodes of gastro

294 We evaluated adrenal function using short corticotropin stimulation test in patients with cirrhosi

295 correlated with a lower cortisol response to corticotropin stimulation.

296 , contributed to hypercortisolemia and hence corticotropin suppression.

297 Corticotropin was detected in steroidogenic cells arrang

298 The cortisol response to corticotropin was inversely correlated with Model for En

299 The release of adrenal corticotropin was stimulated by ligands of aberrant memb

300 ushing's syndrome appears to be regulated by corticotropin, which is produced by a subpopulation of s